You are advising a clinician who needs to choose an add-on therapy for a type 2 diabetes patient on insulin with HbA1c â‰¥7%.

**Compare DPP-4 inhibitors vs SGLT2 inhibitors:**

1. Which has better cardiovascular outcomes?
2. Which has lower hypoglycemia risk?
3. Which is more favorable for body weight?

Cite primary sources.
